LUMBOVERTEBRAL SYNDROME AFTER EXTRADURAL BLOOD PATCH

We describe a patient who developed an immobilizing lumbovertebralsyndrome after an extradural blood patch and who was hospitalizedwith a. suspected extradural abscess. An infectious aetiologyof the persistent backache could be excluded and the patientrecovered with analgesics and physiotherapy. The probable aetiologyis discussed.     

Electromyographic activity while performing the anti-G straining maneuver during high sustained acceleration.

The purpose of this study was to measure the muscle activity during performance of the anti-G straining maneuver (AGSM) at high sustained acceleration stress (+Gz = head-to-foot inertial loading). Ten males were exposed on three separation occasions to a rapid onset rate of 6 + Gz. Subjects wore standard United States Air Force (USAF) anti-G trousers and performed the AGSM until perceived fatigue or until achieving light loss criteria. During each exposure, surface electromyography (EMG) was recorded from the erector spinae, external oblique, bicep femoris, vastus lateralis, and lateral gastrocnemius muscles. The normalized root-mean squares (RMS) and mean power frequency (MPF) for each muscle were calculated and tested for significant differences with an analysis of variance (ANOVA) procedure. The results of this study showed that mean amplitude decreased during the AGSM (35.40%) while MPF showed no significant change. The EMG amplitude of lower extremity muscles decreased (61.45%) while the amplitude of trunk muscles decreased slightly (3.45%). These results indicate that during the performance of the AGSM, motor unit recruitment in lower extremity muscles decrease without evidence of fatigue.     

Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity

Background: The association between aluminium and dialysis encephalopathy and deterioration of the neurological state during desferrioxamine treatment of dialysis patients is well established. At present little is known about the speciation and the mechanisms underlying the element's neurotoxicity. Methods. Aluminium speciation was performed in cerebrospinal fluid samples of acutely aluminium-intoxicated dialysis patients using a recently developed high-performance liquid chromatographic/electro-thermal atomic absorption spectrometric hybrid method. Results: Baseline cerebrospinal fluid aluminium levels of samples taken shortly after the intoxication were low but elevated (5.0±2.0 &mgr;g/l, n=3) as compared to subjects with normal renal function (<1 &mgr;g/l). In contrast to the situation noted in serum and to the iron speciation in cerebrospinal fluid, aluminium was not bound to transferrin but appeared as two distinct compounds, the main fraction eluting at the elution volume of aluminium citrate/silicate. The second compound was not identified. Forty-four hours after desferrioxamine administration the cerebrospinal fluid aluminium levels had increased up to a concentration of 10.3±2.5 &mgr;g/l (n=3). This was accompanied by a change in the speciation profile with aluminium appearing at the elution volume of aluminoxamine. Conclusion: Our findings may contribute to a better understanding of the neurotoxic effects of aluminium and its desferrioxamine chelate in dialysis patients.     

Distal Penile Gangrene in a Patient with Chronic Renal Failure

To date, only 10 cases of distal penile gangrene in patients with chronic renal failure have been reported. This rare condition is believed to result from progressive vascular calcification due to secondary hyperparathyroidism in patients with chronic renal failure. We report an additional case of distal penile gangrene in a 41-year-old man who presented with chronic renal disease and pulmonary tuberculosis. Since some authors have emphasized that aggressive surgical treatment in such cases has a significant mortality rate, we took a more conservative approach to treatment.